Intrathecal or intraventricular administration of colistin, vancomycin and amikacin for central nervous system infections in neurosurgical patients in an intensive care unit

Int J Antimicrob Agents. 2017 Mar;49(3):389-390. doi: 10.1016/j.ijantimicag.2017.01.002. Epub 2017 Feb 2.

Authors

Angeliki Tsimogianni¹, Panagiotis Alexandropoulos², Vasiliki Chantziara², Aimilia Vassi², Georgia Micha², Fotini Lagiou², Efrosini Chinou³, Georgios Michaloudis², Serafeim Georgiou²

Affiliations

¹ ICU Department, 'Saint Savvas' Oncology Hospital, Athens, Greece. Electronic address: linatsim18@gmail.com.
² ICU Department, 'Saint Savvas' Oncology Hospital, Athens, Greece.
³ Microbiology Department, 'Saint Savvas' Oncology Hospital, Athens, Greece.

PMID: 28163138
DOI: 10.1016/j.ijantimicag.2017.01.002

No abstract available

Publication types

Letter
Observational Study

MeSH terms

Amikacin / administration & dosage*
Amikacin / adverse effects
Anti-Bacterial Agents / administration & dosage*
C-Reactive Protein / analysis
Central Nervous System Infections / blood
Central Nervous System Infections / drug therapy*
Colistin / administration & dosage*
Colistin / adverse effects
Humans
Injections, Intraventricular
Injections, Spinal
Intensive Care Units
Neurosurgical Procedures
Retrospective Studies
Vancomycin / administration & dosage*
Vancomycin / adverse effects

Substances

Anti-Bacterial Agents
Vancomycin
Amikacin
C-Reactive Protein
Colistin